(3R,3aS,6aS)-5-(tert-Butoxycarbonyl)hexahydro-2H-furo[2,3-c]pyrrole-3-carboxylic acid, 95%, 2g

2-[methyl(2,2,2-trifluoroethyl)amino]ethan-1-ol, 95%, 50mg

Triphenylene-2,3,6,7,10,11-hexaamine, 98%, 1g

Plan phase S40x/0.65 infinity corrected objective

1,2-Di(4-bromophenyl)-1,2-diphenylethylene, 97%, 25g

5-phenyl-4H-1,2,4-triazol-3-amine hydrochloride, 98%, 1g

3,3'-Bipyridine, 95.0%, 5g

2-Hydroxy-4-isopropylbenzaldehyde, 97%, 5g

(Z)-hex-3-en-1-yl (Z)-hex-3-enoate, 98%, 25g

3-Allyl-4,5-diethoxy-benzaldehyde, 95.0%, 5g

1-((2R,3R,4R,5R)-4-((tert-Butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)-3-methoxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, 95%, 250mg

2-Bromo-4-chloro-3-fluorobenzaldehyde, 95%, 5g

Ethyl 2-(4-acetylphenyl)acetate, 98%, 5g